Your browser doesn't support javascript.
loading
Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years.
Zhu, Hong-Hong; Sun, Guo-Qing; Wu, Ji-Yu; Fan, Su-Qing; Zhu, Ying-Ying; Wang, Zhi-Cheng; Liao, Xiao-Fang.
Afiliación
  • Zhu HH; Center for Medical Research, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Sun GQ; Department of Medical Laboratory Science, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Wu JY; Department of Informatics, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Fan SQ; Department of Medical Laboratory Science, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Zhu YY; Department of Medical Laboratory Science, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Wang ZC; Department of Quality Assurance and Control, Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
  • Liao XF; President for the Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (TCM) - Quzhou Hospital of TCM, Quzhou, Zhejiang, China.
Front Immunol ; 14: 1212988, 2023.
Article en En | MEDLINE | ID: mdl-37583700
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza